OpenAI and journalism

OpenAI outlines the next phase of enterprise AI, as adoption accelerates across industries with Frontier, ChatGPT Enterprise, Codex, and company-wide…

OpenAI is acquiring Orchestra Bio to bring AI-powered operations to life sciences R&D, helping biopharma teams accelerate drug development and…